Patent · US Active

Insulin derivative formulations for pulmonary delivery

US8900555B2 · kind B2 · utility

11Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2007
Grant dateDec 2, 2014
Priority date—
Expiry dateNov 22, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aerosolizable formulations comprising: an insulin derivative having an isoelectric point (pI) ranging from about 6 to about 8; and a pharmaceutically acceptable excipient including a precipitating agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.